Rob Carlson

Founder at Bioeconomy Capital LLC

Health Technology

Consumer Services

Finance

Profile

Rob Carlson is the founder of Bioeconomy Capital LLC, which was founded in 2014.
He is currently a Director at RoosterBio, Inc. since 2013 and a Director at Lumen Bioscience, Inc. He previously worked as an Advisor at Samurai Sword Corp., a Senior Scientist at the University of Washington, and a Scientific Advisor at The Hastings Center.
Dr. Carlson received his undergraduate degree from the University of Washington and his doctorate from Princeton University.

Rob Carlson active positions

Companies	Position	Start
Bioeconomy Capital LLC Bioeconomy Capital LLC Investment ManagersFinance Bioeconomy Capital LLC (Bioeconomy Capital) is a venture capital firm founded in 2014 by Rob Carlson and Rik Wehbring. The firm is headquartered in Seattle, Washington.	Founder	31/12/2013
Lumen Bioscience, Inc. Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA.	Director/Board Member	-
RoosterBio, Inc. RoosterBio, Inc. BiotechnologyHealth Technology RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.	Director/Board Member	30/06/2013

All active positions of Rob Carlson

Former positions of Rob Carlson

Companies	Position	End
Samurai Sword Corp. Samurai Sword Corp. BiotechnologyHealth Technology Samurai Sword Corp. generates biochemical and bioenergy products. Its AGATE (Acid, Gas, and Ammonia Targeted Extraction) technology utilizes modified anaerobic fermentation (like brewing beer) and non-GMO bacterial consortia to produce biochemicals, biomethane, biohydrogen, and nitrogen compounds. The company was founded by Kelly M. Ogilvie and James Stephens in 2005 and is headquartered in Missoula, MT.	Corporate Officer/Principal	-
University of Washington University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.	Corporate Officer/Principal	-
The Hastings Center	Corporate Officer/Principal	-

See the detail of Rob Carlson's experience

Training of Rob Carlson

University of Washington	Undergraduate Degree
Princeton University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rob Carlson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Samurai Sword Corp. Samurai Sword Corp. BiotechnologyHealth Technology Samurai Sword Corp. generates biochemical and bioenergy products. Its AGATE (Acid, Gas, and Ammonia Targeted Extraction) technology utilizes modified anaerobic fermentation (like brewing beer) and non-GMO bacterial consortia to produce biochemicals, biomethane, biohydrogen, and nitrogen compounds. The company was founded by Kelly M. Ogilvie and James Stephens in 2005 and is headquartered in Missoula, MT.	Health Technology
RoosterBio, Inc. RoosterBio, Inc. BiotechnologyHealth Technology RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.	Health Technology
The Hastings Center
Bioeconomy Capital LLC Bioeconomy Capital LLC Investment ManagersFinance Bioeconomy Capital LLC (Bioeconomy Capital) is a venture capital firm founded in 2014 by Rob Carlson and Rik Wehbring. The firm is headquartered in Seattle, Washington.	Finance
Lumen Bioscience, Inc. Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA.	Health Technology

See company connections